CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities:
Net income	$ 780,000,000	$ 569,000,000
Adjustments to reconcile net income to net cash provided by operating activities:
Deferred income taxes	209,000,000	29,000,000
Depreciation and amortization	47,000,000	45,000,000
Amortization and write-off of capitalized software development costs and intellectual property licenses	126,000,000	102,000,000
Stock-based compensation expense	50,000,000	49,000,000
Excess tax benefits from stock option exercises	(5,000,000)	(3,000,000)
Changes in operating assets and liabilities:
Accounts receivable, net	583,000,000	421,000,000
Inventories, net	76,000,000	15,000,000
Software development and intellectual property licenses	(140,000,000)	(146,000,000)
Other assets	132,000,000	246,000,000
Deferred revenues	(974,000,000)	(564,000,000)
Accounts payable	(197,000,000)	(228,000,000)
Accrued expenses and other liabilities	(253,000,000)	(290,000,000)
Net cash provided by operating activities	434,000,000	245,000,000
Cash flows from investing activities:
Proceeds from maturities of available-for-sale-investments	229,000,000	253,000,000
Purchases of available-for-sale investments	(26,000,000)	(302,000,000)
Capital expenditures	(36,000,000)	(26,000,000)
(Increase) decrease in restricted cash	9,000,000	1,000,000
Net cash provided by (used in) investing activities	176,000,000	(74,000,000)
Cash flows from financing activities:
Proceeds from issuance of common stock to employees	51,000,000	23,000,000
Tax payment related to net share settlements of restricted stock rights	(16,000,000)	(3,000,000)
Repurchase of common stock	0	(315,000,000)
Dividends paid	(216,000,000)	(204,000,000)
Excess tax benefits from stock option exercises	5,000,000	3,000,000
Net cash provided by (used in) financing activities	(176,000,000)	(496,000,000)
Effect of foreign exchange rate changes on cash and cash equivalents	(52,000,000)	(54,000,000)
Net increase (decrease) in cash and cash equivalents	382,000,000	(379,000,000)
Cash and cash equivalents at beginning of period	3,959,000,000	3,165,000,000
Cash and cash equivalents at end of period	$ 4,341,000,000	$ 2,786,000,000